SCHEMBL7909762

SCHEMBL7909762

COc1ccc(OC(F)(F)F)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RUNX1 Q01196 1/20 0.40
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
VNN1 O95497 1/20 0.38
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
LMNA P02545 1/20 0.37
HAO1 Q9UJM8 1/20 0.37
LIPE Q05469 1/20 0.36
NFE2L2 Q16236 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27775336 0.82 KDM4E (0.41) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL29525223 0.79 NNMT (0.48) CA12CA1CA2CA7CA9
SCHEMBL3816388 0.79 NNMT (0.48) CA12CA1CA2CA7CA9
SCHEMBL27931908 0.77 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC5TSHR
SCHEMBL7996271 0.76 CCR1 (0.43) HDAC6TSHRSMN1; SMN2LIPEKDM4E
SCHEMBL28806907 0.75 SCN5A (0.46) HDAC1HDAC8HDAC6HDAC5KCNH2
SCHEMBL9061186 0.75 MKNK1 (0.50) CA12CA9SCN1AKCNH2SCN5A
SCHEMBL16838765 0.75 LMNA (0.59) TSHRSMN1; SMN2LMNALIPEKDM4E
SCHEMBL16559590 0.74 NFE2L2 (0.40) HDAC1HDAC8HDAC6HDAC5CA1
SCHEMBL23636837 0.73 SLC7A5 (0.39) LMNAKDM4EALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225320-B1 TREATMENT OF PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTTHERPETIC NEURALGIA MERCK SHARP & DOHME LTD. (GB) 2001-05-01 US disclosed
EP-0989987-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2000-04-05 EP disclosed
WO-1998054187-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 1998-12-03 WO disclosed